Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population

Yasuhisa Fukuo, Taro Kishi, Itaru Kushima, Reiji Yoshimura, Tomo Okochi, Tsuyoshi Kitajima, Shinji Matsunaga, Kunihiro Kawashima, Wakako Umene-Nakano, Hiroshi Naitoh, Toshiya Inada, Jun Nakamura, Norio Ozaki, Nakao Iwata

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Several investigations have reported that abnormalities in circadian rhythms might be related to the pathophysiology of major depressive disorder (MDD) and the therapeutic response to selective serotonin reuptake inhibitors (SSRIs). Recently, ubiquitin-specific peptidase 46 (USP46), a new molecule related to the circadian clock system, has been described. We conducted a case control study between seven tagging SNPs (rs10517263, rs17675844, rs6554557, rs12646800, rs2244291, rs10034164, rs346005) in the USP46 gene, MDD, and the SSRI therapeutic response in MDD in the Japanese population. Method: We recruited 432 MDD patients (202 males and 230 females) and 792 healthy controls (319 males and 473 females). Two hundred sixty-one of 432 MDD patients were treated with SSRIs (fluvoxamine, sertraline or paroxetine). Result: We detected an association between the USP46 gene and MDD in a haplotype analysis (rs2244291-rs10034164-rs346005 and rs12646800-rs2244291-rs10034164-rs346005). However, we did not find any association between the USP46 gene and SSRI response or remission in MDD in the Japanese population. Limitations: A replication study using larger samples may be required for conclusive results, since our sample size was small. Conclusions: Our results suggest that the USP46 gene might play a role in the pathophysiology of MDD in the Japanese population.

Original languageEnglish
Pages (from-to)150-157
Number of pages8
JournalJournal of Affective Disorders
Volume133
Issue number1-2
DOIs
Publication statusPublished - 01-09-2011

Fingerprint

Major Depressive Disorder
Ubiquitin
Peptide Hydrolases
Serotonin Uptake Inhibitors
Population
Genes
Fluvoxamine
Sertraline
Paroxetine
Circadian Clocks
Circadian Rhythm
Sample Size
Haplotypes
Single Nucleotide Polymorphism
Case-Control Studies
Therapeutics

All Science Journal Classification (ASJC) codes

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Fukuo, Yasuhisa ; Kishi, Taro ; Kushima, Itaru ; Yoshimura, Reiji ; Okochi, Tomo ; Kitajima, Tsuyoshi ; Matsunaga, Shinji ; Kawashima, Kunihiro ; Umene-Nakano, Wakako ; Naitoh, Hiroshi ; Inada, Toshiya ; Nakamura, Jun ; Ozaki, Norio ; Iwata, Nakao. / Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population. In: Journal of Affective Disorders. 2011 ; Vol. 133, No. 1-2. pp. 150-157.
@article{7600a23e62f640eb80012f7a11ee15a9,
title = "Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population",
abstract = "Background: Several investigations have reported that abnormalities in circadian rhythms might be related to the pathophysiology of major depressive disorder (MDD) and the therapeutic response to selective serotonin reuptake inhibitors (SSRIs). Recently, ubiquitin-specific peptidase 46 (USP46), a new molecule related to the circadian clock system, has been described. We conducted a case control study between seven tagging SNPs (rs10517263, rs17675844, rs6554557, rs12646800, rs2244291, rs10034164, rs346005) in the USP46 gene, MDD, and the SSRI therapeutic response in MDD in the Japanese population. Method: We recruited 432 MDD patients (202 males and 230 females) and 792 healthy controls (319 males and 473 females). Two hundred sixty-one of 432 MDD patients were treated with SSRIs (fluvoxamine, sertraline or paroxetine). Result: We detected an association between the USP46 gene and MDD in a haplotype analysis (rs2244291-rs10034164-rs346005 and rs12646800-rs2244291-rs10034164-rs346005). However, we did not find any association between the USP46 gene and SSRI response or remission in MDD in the Japanese population. Limitations: A replication study using larger samples may be required for conclusive results, since our sample size was small. Conclusions: Our results suggest that the USP46 gene might play a role in the pathophysiology of MDD in the Japanese population.",
author = "Yasuhisa Fukuo and Taro Kishi and Itaru Kushima and Reiji Yoshimura and Tomo Okochi and Tsuyoshi Kitajima and Shinji Matsunaga and Kunihiro Kawashima and Wakako Umene-Nakano and Hiroshi Naitoh and Toshiya Inada and Jun Nakamura and Norio Ozaki and Nakao Iwata",
year = "2011",
month = "9",
day = "1",
doi = "10.1016/j.jad.2011.04.020",
language = "English",
volume = "133",
pages = "150--157",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",
number = "1-2",

}

Fukuo, Y, Kishi, T, Kushima, I, Yoshimura, R, Okochi, T, Kitajima, T, Matsunaga, S, Kawashima, K, Umene-Nakano, W, Naitoh, H, Inada, T, Nakamura, J, Ozaki, N & Iwata, N 2011, 'Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population', Journal of Affective Disorders, vol. 133, no. 1-2, pp. 150-157. https://doi.org/10.1016/j.jad.2011.04.020

Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population. / Fukuo, Yasuhisa; Kishi, Taro; Kushima, Itaru; Yoshimura, Reiji; Okochi, Tomo; Kitajima, Tsuyoshi; Matsunaga, Shinji; Kawashima, Kunihiro; Umene-Nakano, Wakako; Naitoh, Hiroshi; Inada, Toshiya; Nakamura, Jun; Ozaki, Norio; Iwata, Nakao.

In: Journal of Affective Disorders, Vol. 133, No. 1-2, 01.09.2011, p. 150-157.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population

AU - Fukuo, Yasuhisa

AU - Kishi, Taro

AU - Kushima, Itaru

AU - Yoshimura, Reiji

AU - Okochi, Tomo

AU - Kitajima, Tsuyoshi

AU - Matsunaga, Shinji

AU - Kawashima, Kunihiro

AU - Umene-Nakano, Wakako

AU - Naitoh, Hiroshi

AU - Inada, Toshiya

AU - Nakamura, Jun

AU - Ozaki, Norio

AU - Iwata, Nakao

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Background: Several investigations have reported that abnormalities in circadian rhythms might be related to the pathophysiology of major depressive disorder (MDD) and the therapeutic response to selective serotonin reuptake inhibitors (SSRIs). Recently, ubiquitin-specific peptidase 46 (USP46), a new molecule related to the circadian clock system, has been described. We conducted a case control study between seven tagging SNPs (rs10517263, rs17675844, rs6554557, rs12646800, rs2244291, rs10034164, rs346005) in the USP46 gene, MDD, and the SSRI therapeutic response in MDD in the Japanese population. Method: We recruited 432 MDD patients (202 males and 230 females) and 792 healthy controls (319 males and 473 females). Two hundred sixty-one of 432 MDD patients were treated with SSRIs (fluvoxamine, sertraline or paroxetine). Result: We detected an association between the USP46 gene and MDD in a haplotype analysis (rs2244291-rs10034164-rs346005 and rs12646800-rs2244291-rs10034164-rs346005). However, we did not find any association between the USP46 gene and SSRI response or remission in MDD in the Japanese population. Limitations: A replication study using larger samples may be required for conclusive results, since our sample size was small. Conclusions: Our results suggest that the USP46 gene might play a role in the pathophysiology of MDD in the Japanese population.

AB - Background: Several investigations have reported that abnormalities in circadian rhythms might be related to the pathophysiology of major depressive disorder (MDD) and the therapeutic response to selective serotonin reuptake inhibitors (SSRIs). Recently, ubiquitin-specific peptidase 46 (USP46), a new molecule related to the circadian clock system, has been described. We conducted a case control study between seven tagging SNPs (rs10517263, rs17675844, rs6554557, rs12646800, rs2244291, rs10034164, rs346005) in the USP46 gene, MDD, and the SSRI therapeutic response in MDD in the Japanese population. Method: We recruited 432 MDD patients (202 males and 230 females) and 792 healthy controls (319 males and 473 females). Two hundred sixty-one of 432 MDD patients were treated with SSRIs (fluvoxamine, sertraline or paroxetine). Result: We detected an association between the USP46 gene and MDD in a haplotype analysis (rs2244291-rs10034164-rs346005 and rs12646800-rs2244291-rs10034164-rs346005). However, we did not find any association between the USP46 gene and SSRI response or remission in MDD in the Japanese population. Limitations: A replication study using larger samples may be required for conclusive results, since our sample size was small. Conclusions: Our results suggest that the USP46 gene might play a role in the pathophysiology of MDD in the Japanese population.

UR - http://www.scopus.com/inward/record.url?scp=80051667505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051667505&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2011.04.020

DO - 10.1016/j.jad.2011.04.020

M3 - Article

C2 - 21663972

AN - SCOPUS:80051667505

VL - 133

SP - 150

EP - 157

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

IS - 1-2

ER -